London close: Stocks fall ahead of US Fed decision

1st May 2024 16:42

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more

Haleon makes 'solid start' to FY24

1st May 2024 09:10

(Sharecast News) - Consumer healthcare company Haleon said on Wednesday that it had made a "solid start to the year", posting better-than-expected Q1 profits despite seeing a fall in revenues.

Read more

London close: Stocks follow Wall Street into the red

30th Apr 2024 17:08

(Sharecast News) - London markets closed in the red on Tuesday, turning weaker during the afternoon to mirror the decline in Wall Street equities, as investors monitored the start of the Federal Reserve's two-day policy meeting.

Read more

Wednesday preview: Federal Reserve, Haleon in focus

30th Apr 2024 13:27

(Sharecast News) - Investors' focus in the middle of the week will be on the U.S. central bank.

Read more

Haleon too shut Maidenhead factory, putting 435 jobs at risk

30th Apr 2024 12:01

(Sharecast News) - Haleon, the British healthcare company behind brands like Sensodyne and Panadol, is expected to announce 435 job cuts over the next two years due to plans to shut its Maidenhead manufacturing plant.

Read more

Haleon nabs finance chief from Tate & Lyle as CFO steps down

24th Apr 2024 07:41

(Sharecast News) - The chief financial officer of consumer health company Haleon is to step down after three years and will be replaced by Tate & Lyle's CFO Dawn Allen.

Read more

London close: Stocks mixed as Japan ends negative rate policy

19th Mar 2024 16:23

(Sharecast News) - London markets closed with a mixed performance on Tuesday, as investors weighed the implications of Japan's decision to end negative interest rates against upcoming policy announcements from the US Federal Reserve and the Bank of England later in the week.

Read more

Pfizer sells bigger-than-expected stake in Haleon

19th Mar 2024 09:39

(Sharecast News) - Haleon said on Tuesday that Pfizer has sold a larger-than-expected stake in the consumer healthcare group, taking its interest down to 22.6% from 32%.

Read more

London close: Stocks slip ahead of central bank decisions

18th Mar 2024 15:33

(Sharecast News) - London markets closed with a slight downturn on Monday as investors monitored upcoming rate decisions from a number of central banks.

Read more

Pfizer to cut stake in Haleon to 24% from 32%

18th Mar 2024 07:35

(Sharecast News) - Consumer healthcare company Haleon said on Monday that Pfizer plans to sell around 630m shares in the company in a public offering.

Read more

London close: Stocks fall as US inflation tops forecasts

14th Mar 2024 16:33

(Sharecast News) - London's equity markets finished in negative territory on Thursday, driven by a flurry of stocks going ex-dividend and investor reactions to the latest US producer inflation and jobless data.

Read more

London close: Stocks finish positive as US inflation moderates

29th Feb 2024 16:05

(Sharecast News) - London's stock markets finished with moderate gains on Thursday, buoyed by a combination of factors including a slowdown in US inflation, robust UK earnings reports, and encouraging mortgage approvals figures.

Read more

Haleon sees higher sales in 2024 as FY profits come in flat

29th Feb 2024 07:23

(Sharecast News) - Consumer health firm Haleon on Thursday posted flat annual earnings and said it expected to grow revenue this year on higher demand.

Read more

Haleon offloads ChapStick brand for $430m

25th Jan 2024 07:14

(Sharecast News) - Consumer health group Haleon, the company behind Sensodyne toothpaste, Panadol and Advil painkillers, has announced it is selling the ChapStick lip balm brand for $430m.

Read more

London close: Stocks rise on positive news from China

24th Jan 2024 16:31

(Sharecast News) - London markets finished with a positive performance on Wednesday, driven by gains in the mining sector following China's announcement of an upcoming reduction in the reserve requirement ratio for banks.

Read more